PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML)

Authors
WICKRAMANAVAKE PD STEINMETZ HT KATAY I GLASMACHER A NEUFANG A STAIB P SCHWONZEN M DIEHL V
Citation
Pd. Wickramanavake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000618-10000618
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
84
Issue
10
Year of publication
1994
Supplement
1
Pages
10000618 - 10000618
Database
ISI
SICI code
0006-4971(1994)84:10<10000618:PTOIFC>2.0.ZU;2-X